Epilepsy is a clinical diagnosis based on a detailed description of events. There is no single test which can always make, or exclude, a diagnosis of epilepsy. Moreover, as also explained in earlier chapters, epilepsy is not a single condition. There are many different types of epilepsy, and there are many different causes of epilepsy. Investigations may be useful to:

• add weight to, or support the clinical diagnosis of epilepsy;

• help ‘classify’ the type of epileptic seizure and epilepsy syndrome. This is important in predicting the likely outcome of the epilepsy in a given individual, and the treatment that should be used; and

• help detect or find a cause for the epilepsy.

The main investigations which may be used in epilepsy are the electroencephalogram (EEG) and brain imaging techniques, most commonly computerized tomographic scanning (CT scanning) or magnetic resonance imaging (MRI). Other investigations such as X-rays, blood tests, lumbar puncture (spinal tap), or tissue biopsy are much less commonly undertaken.

*47\188\2*

Product Designation: CMO

Composition: Cerasomal-cis-9-cetylmyristoleate, a mix of special fatty acids.

Classification: Nutritional supplement.

Import-Export Notice: CMO is a mix of special fatty acids that qualify for import into the European common market and Asian countries by virtue of the processing and manufacturing methods used in its production. CMO is heated several times to super pasteurization temperatures as well as twice subjected to vacuum treatment at pressures greater than that required by France (as well as some Asian and other European countries) for ;he import of beef byproducts. The supplier of the raw materials “egularly supplies products of all types to France and all of the European common market countries. The product is derived irom US beef sources exclusively.

Production: The product is manufactured in a GMP licensed facility according to quality standards defined by the US Government for the production of dietary and nutritional supplements. All production methods conform to Good Manufacturing Practices prescribed by government agency standards.

Agency Inspections: The facility is routinely inspected without notice on a semi-annual basis by Food and Drug Inspectors of the resident state’s Department of Health Services according to a schedule controlled by that agency.

Product Source: Natural bovine tallow from US cattle.

Bio-Identification: A free mono-unsaturated fatty acid wax in a mix of related natural

tallow-derived waxes.

Melting Point: 34-39°C

Differential Thermal Analysis (DTA): Minimum between 50-60°C with thermogram structure depending on scan rate and packing of sample tube. Matches standards.

Infrared Spectrum: Neat on NaCl plates. Matches standards.

Microbial Testing: Plate count: <10cfu per gram /

E. Coli: Negative. / Salmonella: Negative.

Toxicity: No toxic solvents or other toxic materials are used in the extraction process from its source or in any subsequent processing or handling. Consequently there is no toxic residue in the finished product.

Safety: Closely related fatty acid waxes have for centuries been used in the processing of common foods. They are found in just about every chocolate and natural cheese produced

world-wide. They are also commonly used by drug manufacturers in the shells of coated pharmaceutical pills. They are commonly used, as well, in most cosmetics like lipstick and rouge.

Warnings: No product warnings are required. However, as a precautionary measure, it’s customary to include the usual text of “Store in a cool dry place out of direct sunlight” and “Keep out of the reach of children” and “Consult your doctor” on any label and as part of any instruction sheet.

Legal History: Since its introduction early in 1995 and use by thousands of consumers, the manufacturer of CMO, its distributors, its dealers, and the medical and other health professionals providing the product have never been sued or otherwise involved in any product litigation. This holds true for any and all other products from the manufacturer as well.

FDA Considerations: CMO is a nutritional supplement. It is derived from natural beef sources as are other common non-prescription products like digestive enzymes and beef liver extract tablets which are freely sold without FDA control. The FDA has never shown any interest in CMO. Just as Cod Liver Oil is a natural product extracted from fish liver, CMO is a natural product derived from certain fatty tissue of US beef.

*68\142\2*

Symptoms: low-grade fever; loss of appetite; headache; swelling of the salivary glands.

Home care:

The child with mumps needs rest. Give aspirin or paracetamol for pain and fever.

Do not give the child spicy foods.

Isolate the child from other family members.

Precautions

-    Make sure that your child is vaccinated against mumps.

-    One attack of mumps provides lifelong immunity. If the child has had mumps, but develops symptoms similar to those of mumps, the problem is some other disease of the salivary glands. Report the problem to the doctor.

-    If mumps involves the ovaries or pancreas, the child will have abdominal pain. If the testes are involved, the testes will be swollen and tender.

-    If a child who has not been vaccinated is exposed to mumps, he or she can receive the vaccine shortly after exposure to the disease to prevent becoming ill with mumps.

Mumps is a moderately contagious infection caused by a specific virus which involves the salivary glands. It is contracted by contact with the saliva of an infected person. The incubation period – the time it takes for symptoms to develop once the child has been exposed to the virus – for mumps is 14 to 21 days, and the disease can be passed on any time from two or more days before symptoms appear until all symptoms have gone. One attack provides lifelong immunity; if a child has had mumps and subsequently develops similar symptoms, the problem is not mumps but some other disease of the salivary gland.

Complications of mumps include meningitis, encephalitis, permanent deafness, and orchitis (inflammation of the male sex glands called the testes). The disease may also involve the ovaries, the female sex glands, or cause an infection of the pancreas.

A vaccine is available to prevent mumps. It is usually given in combination with measles and rubella (German measles) vaccines during the child’s second year at around 15 months of age. This vaccine is 95 percent effective in preventing mumps.

*154/84/5*